Related Experiment Videos
HMO mergers and Medicare: the antitrust issues
Health Economics
|July 4, 1998
Abstract:
This paper presents a theoretical framework to predict the effects that may arise from mergers in the rapidly-growing Medicare HMO market. We argue that mergers of large Medicare HMOs should be targeted for antitrust investigation because there are significant barriers into this market. The recent merger of PacifiCare and FHP is used to illustrate the potential antitrust issues raised by Medicare HMO mergers.
Insights
Mergers of large Medicare Health Maintenance Organizations (HMOs) warrant antitrust scrutiny due to market entry barriers. The PacifiCare and FHP merger exemplifies potential antitrust concerns in this growing sector.
Area of Science:
- Health Economics
- Antitrust Law
- Market Regulation
Background:
- The Medicare Health Maintenance Organization (HMO) market is experiencing rapid growth.
- Significant barriers to entry exist within this market.
- Consolidation through mergers is becoming prevalent.
Purpose of the Study:
- To present a theoretical framework for predicting the effects of mergers in the Medicare HMO market.
- To identify Medicare HMO mergers that should be targeted for antitrust investigation.
- To illustrate potential antitrust issues using a specific merger case.
Main Methods:
- Development of a theoretical framework for merger analysis.
- Application of the framework to the Medicare HMO market.
- Case study analysis of the PacifiCare and FHP merger.
Main Results:
- The theoretical framework predicts significant market effects from large Medicare HMO mergers.
- Mergers involving large Medicare HMOs present substantial antitrust concerns.
- The PacifiCare/FHP merger highlights specific antitrust issues related to market concentration and barriers to entry.
Conclusions:
- Mergers of large Medicare HMOs require antitrust investigation due to inherent market entry barriers.
- The theoretical framework provides a basis for evaluating future Medicare HMO mergers.
- Antitrust vigilance is crucial to maintain competition and protect beneficiaries in the evolving Medicare HMO landscape.